Elevated levels of Substance P and CGRP have been consistently observed in plasma and cerebrospinal fluid (CSF) of patients with chronic pain conditions, particularly fibromyalgia, chronic migraine, and complex regional pain syndrome (CRPS) [72,73,74]. This evidence concerns the gene TAC1 and complex regional pain syndrome.